Orchard JA - Search Results

1

Association of myelodysplastic changes with purine analogues.

Orchard JA, Bolam S, Oscier DG. Orchard JA, et al. Br J Haematol. 1998 Mar;100(4):677-9. doi: 10.1046/j.1365-2141.1998.00612.x. Br J Haematol. 1998. PMID: 9531333 Free article.

2

Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.

Myint H, Copplestone JA, Orchard J, Craig V, Curtis D, Prentice AG, Hamon MD, Oscier DG, Hamblin TJ. Myint H, et al. Among authors: orchard j. Br J Haematol. 1995 Oct;91(2):341-4. doi: 10.1111/j.1365-2141.1995.tb05300.x. Br J Haematol. 1995. PMID: 8547072

3

Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes.

Bolam S, Orchard J, Oscier D. Bolam S, et al. Br J Haematol. 1997 Oct;99(1):158-61. doi: 10.1046/j.1365-2141.1997.3523168.x. Br J Haematol. 1997. PMID: 9359516 Free article.

4

Response to cladribine in previously treated patients with chronic lymphocytic leukaemia identified by ex vivo assessment of drug sensitivity by DiSC assay.

Bosanquet AG, Copplestone JA, Johnson SA, Smith AG, Povey SJ, Orchard JA, Oscier DG. Bosanquet AG, et al. Among authors: orchard ja. Br J Haematol. 1999 Aug;106(2):474-6. doi: 10.1046/j.1365-2141.1999.01581.x. Br J Haematol. 1999. PMID: 10460608 Free article. Clinical Trial.

5

The bioavailability of oral fludarabine phosphate is unaffected by food.

Oscier D, Orchard JA, Culligan D, Cunningham D, Johnson S, Parker A, Klein M, Gieschen H. Oscier D, et al. Among authors: orchard ja. Hematol J. 2001;2(5):316-21. doi: 10.1038/sj.thj.6200113. Hematol J. 2001. PMID: 11920267 Clinical Trial.

6

In patients with lymphoid tumours recovering from the autoimmune complications of fludarabine, relapse may be triggered by conventional chemotherapy.

Orchard J, Bolam S, Myint H, Oscier DG, Hamblin TJ. Orchard J, et al. Br J Haematol. 1998 Sep;102(4):1112-3. doi: 10.1046/j.1365-2141.1998.0952e.x. Br J Haematol. 1998. PMID: 9734670 Free article. No abstract available.

7

Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).

Chasty RC, Myint H, Oscier DG, Orchard JA, Bussutil DP, Hamon MD, Prentice AG, Copplestone JA. Chasty RC, et al. Among authors: orchard ja. Leuk Lymphoma. 1998 Apr;29(3-4):391-8. doi: 10.3109/10428199809068575. Leuk Lymphoma. 1998. PMID: 9684936

8

Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.

Corcoran MM, Mould SJ, Orchard JA, Ibbotson RE, Chapman RM, Boright AP, Platt C, Tsui LC, Scherer SW, Oscier DG. Corcoran MM, et al. Among authors: orchard ja. Oncogene. 1999 Nov 4;18(46):6271-7. doi: 10.1038/sj.onc.1203033. Oncogene. 1999. PMID: 10597225

9

ZAP-70 in B cell malignancies.

Orchard J, Ibbotson R, Best G, Parker A, Oscier D. Orchard J, et al. Leuk Lymphoma. 2005 Dec;46(12):1689-98. doi: 10.1080/09638280500260079. Leuk Lymphoma. 2005. PMID: 16263570 Review.

10

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG. Hamblin TJ, et al. Among authors: orchard ja. Blood. 2002 Feb 1;99(3):1023-9. doi: 10.1182/blood.v99.3.1023. Blood. 2002. PMID: 11807008 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters